Solomon Seeks $3.8M From Spirogen For AstraZeneca Deal

Investment banking advisory firm Peter J. Solomon Co. is suing a British biotech company, formerly known as Spirogen Ltd., seeking $3.75 million in fees for advising the company in its $200 million sale to an AstraZeneca PLC subsidiary, according to a ...read more

  • Tags: